Phase II Pilot Trial of Tislelizumab plus Low-Dose Nab-Paclitaxel for Extensive Very High-Risk Non-Muscle-Invasive Bladder Cancer
替雷利珠单抗联合低剂量白蛋白紫杉醇治疗广泛性极高危非肌层浸润性膀胱癌的II期试点试验
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-3321
Qie, Yunkai; Huang, Shiwang; Shen, Chong; Wu, Zhouliang; Da, La; Jia, Kaipeng; Zhang, Zhe; Zhao, Gangjian; Wang, Lili; Xu, Guoping; Zhao, Yang; Liang, Rui; Guo, Jianing; Li, Changping; Dong, Hua; Li, Man; Li, Hongjun; Chen, Houyuan; Tian, Dawei; Wu, Changli; Zhang, Wei; An, Zesheng; Wang, Haitao; Niu, Yuanjie; Hu, Hailong